WITHDRAWN: HM47118A, a novel insulinotropic GPR119 agonist and potential oral antidiabetic agent

Tae Hun Song; Sang Don Lee; Young Eun Ha; Kyung Jin Choi; Sang Hyun Lee; Young-Hoon Kim; Kwee Hyun Suh; Young-Jin Chun

doi:10.1016/j.diabres.2019.01.011

WITHDRAWN: HM47118A, a novel insulinotropic GPR119 agonist and potential oral antidiabetic agent

Diabetes Res Clin Pract. 2019 Jan 11;S0168-8227(18)31385-8. doi: 10.1016/j.diabres.2019.01.011. Online ahead of print.

Authors

Tae Hun Song¹, Sang Don Lee², Young Eun Ha², Kyung Jin Choi², Sang Hyun Lee², Young-Hoon Kim², Kwee Hyun Suh², Young-Jin Chun³

Affiliations

¹ Hanmi Research Center, Hanmi Pharm. Co., Ltd., 550 Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do 18469, Republic of Korea; College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Seoul 06974, Republic of Korea.
² Hanmi Research Center, Hanmi Pharm. Co., Ltd., 550 Dongtangiheung-ro, Hwaseong-si, Gyeonggi-do 18469, Republic of Korea.
³ College of Pharmacy, Chung-Ang University, 84 Heukseok-ro, Seoul 06974, Republic of Korea. Electronic address: yjchun@cau.ac.kr.

PMID: 30641165
DOI: 10.1016/j.diabres.2019.01.011

Abstract

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.

Publication types

Retraction of Publication